105
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5413-5423 | Received 06 Aug 2022, Accepted 10 Sep 2022, Published online: 18 Sep 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.